Farnesyl-transferase inhibitors show synergistic anticancer effects in combination with novel KRAS-G12C inhibitors

被引：0
|
作者：
Marcell Baranyi
Eszter Molnár
Luca Hegedűs
Zsófia Gábriel
Flóra Gréta Petényi
Fanni Bordás
Violetta Léner
Ivan Ranđelović
Mihály Cserepes
József Tóvári
Balázs Hegedűs
József Tímár
机构：
[1] Semmelweis University,Department of Pathology, Forensic and Insurance Medicine
[2] KINETO Lab Ltd,Department of Thoracic Surgery
[3] University Medicine Essen - Ruhrlandklinik,Department of Anatomy, Cell and Developmental Biology
[4] University Duisburg-Essen,Department of Experimental Pharmacology and the National Tumor Biology Laboratory
[5] Pázmány Péter Catholic University Faculty of Information Technology and Bionics,undefined
[6] Eötvös Loránd University,undefined
[7] National Institute of Oncology,undefined
来源：
British Journal of Cancer | 2024年 / 130卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1059 / 1072
页数：13
相关论文
共 50 条
  • [21] Role of AXL activation on adaptive resistance to KRAS-G12C inhibitors in KRAS-G12C-mutated non-small cell lung cancer
    Yamada, T.
    Morimoto, K.
    Hirai, S.
    Katayama, Y.
    Kunimasa, K.
    Sasaki, T.
    Nishida, M.
    Watanabe, S.
    Shiotsu, S.
    Uehara, H.
    Takayama, K.
    ANNALS OF ONCOLOGY, 2023, 34 : S194 - S194
  • [22] Combination of tipifarnib with KRAS G12C inhibitors to prevent adaptive resistance
    Patel, Hetika Vora
    Smith, Alison
    Chan, Stacia
    Kessler, Linda
    Burrows, Francis
    Malik, Shivani
    CANCER RESEARCH, 2023, 83 (07)
  • [23] Discovery of novel potent allele-selective KRAS-G12C covalent inhibitors stemming from DNA-encoded library
    McCort, Gary
    Arrebola, Rosalia
    Calvet, Loreley
    Ronan, Baptiste
    Vergne, Fabrice
    Duffieux, Francis
    Rak, Alexey
    Meaux, Isabelle
    Papin, David
    Fassy, Florence
    Delorme, Cecile
    Matthieu, Magali
    Nicolas, Jean-Paul
    Marcireau, Christophe
    Steier, Valerie
    Abecassis, Pierre-Yves
    Czepczor, Valerie
    Thomson, Heather A.
    Hupp, Christopher D.
    Guilinger, J. P.
    Zhang, Ying
    Keefe, Anthony D.
    Cuozzo, John W.
    Liu, Julie
    Debussche, Laurent
    CANCER RESEARCH, 2019, 79 (13)
  • [24] Identification of novel Pyrrolo[2,3-d]Pyrimidine-based KRAS G12C inhibitors with anticancer effects
    Song, Zhendong
    Lou, Linlin
    Fan, Guangjin
    Liu, Lu
    Ge, Yang
    Liu, He
    Chan, Albert S. C.
    Zhang, Xiaolei
    Xiong, Xiao-Feng
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2023, 245
  • [25] Novel natural inhibitors targeting KRAS G12C by computational study
    Jiang, Yuting
    Chen, Wanting
    Wang, Xinhui
    Zhou, Baolin
    Xie, Haoqun
    Hou, Yuanyuan
    Guo, Zhen
    Yu, Bo
    Zhong, Sheng
    Su, Xing
    ANTI-CANCER DRUGS, 2022, 33 (09) : 779 - 788
  • [26] Mechanisms of Resistance to KRAS G12C Inhibitors
    Ambrogio, C.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (03) : S96 - S96
  • [27] Clinical Data for KRAS G12C Inhibitors
    Kim, H. R.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (03) : S95 - S96
  • [28] The promise and peril of KRAS G12C inhibitors
    Moore, Amanda R.
    Malek, Shiva
    CANCER CELL, 2021, 39 (08) : 1059 - 1061
  • [29] Targeting KRAS G12C with Covalent Inhibitors
    Ostrem, Jonathan M. L.
    Shokat, Kevan M.
    ANNUAL REVIEW OF CANCER BIOLOGY, 2022, 6 : 49 - 64
  • [30] Synergistic antitumor activity of nab-sirolimus in combination with KRAS inhibitors (KRASis) sotorasib and adagrasib in KRAS G12C NSCLC and bladder cancer xenografts
    Hou, Shihe
    Kwon, Andrew
    Nieva, Jorge
    Desai, Neil
    CANCER RESEARCH, 2023, 83 (07)
12345